Ross Moat Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Ross Moat is CHIEF COMMERCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 16,276 shares of KNSA, which is worth approximately $300,292. The most recent transaction as insider was on Apr 08, 2024, when has been sold 1,353 shares (Class A Common Share) at a price of $17.9 per share, resulting in proceeds of $24,218. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.3K

7.42% 3M change

29.66% 12M change

Total Value Held $300,292

Ross Moat Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 08 2024	SELL Payment of exercise price or tax liability	$24,218 $17.9 p/Share	1,353 Reduced 7.67%	16,276 Class A Common Share
Apr 08 2024	BUY Exercise of conversion of derivative security	-	2,477 Added 12.32%	17,629 Class A Common Share
Apr 01 2024	SELL Payment of exercise price or tax liability	$17,336 $19.7 p/Share	880 Reduced 5.49%	15,152 Class A Common Share
Apr 01 2024	BUY Exercise of conversion of derivative security	-	1,612 Added 9.14%	16,032 Class A Common Share
Sep 02 2023	SELL Payment of exercise price or tax liability	$9,643 $17.76 p/Share	543 Reduced 3.63%	14,420 Class A Common Share
Sep 02 2023	BUY Exercise of conversion of derivative security	-	994 Added 6.23%	14,963 Class A Common Share
Sep 01 2023	SELL Payment of exercise price or tax liability	$24,029 $17.76 p/Share	1,353 Reduced 8.83%	13,969 Class A Common Share

Sep 01 2023	BUY Exercise of conversion of derivative security	-	2,477 Added 13.92%	15,322 Class A Common Share
Jul 15 2023	BUY Grant, award, or other acquisition	$3,606 $12.35 p/Share	292 Added 2.22%	12,845 Class A Common Share
Apr 10 2023	SELL Payment of exercise price or tax liability	$14,490 $10.71 p/Share	1,353 Reduced 9.73%	12,553 Class A Common Share
Apr 10 2023	BUY Exercise of conversion of derivative security	-	2,477 Added 15.12%	13,906 Class A Common Share
Mar 20 2023	SELL Payment of exercise price or tax liability	$12,977 $11.12 p/Share	1,167 Reduced 9.26%	11,429 Class A Common Share
Mar 20 2023	BUY Exercise of conversion of derivative security	-	2,137 Added 14.5%	12,596 Class A Common Share
Mar 16 2023	SELL Payment of exercise price or tax liability	$6,222 $11.46 p/Share	543 Reduced 4.94%	10,459 Class A Common Share
Mar 16 2023	BUY Exercise of conversion of derivative security	-	994 Added 8.29%	11,002 Class A Common Share
Jan 15 2023	BUY Grant, award, or other acquisition	$17,628 $9.56 p/Share	1,844 Added 15.56%	10,008 Class A Common Share
Sep 02 2022	SELL Payment of exercise price or tax liability	$6,441 $11.44 p/Share	563 Reduced 6.45%	8,164 Class A Common Share
Sep 02 2022	BUY Exercise of conversion of derivative security	-	995 Added 10.23%	8,727 Class A Common Share
Jul 15 2022	BUY Grant, award, or other acquisition	$3,442 $9.56 p/Share	360 Added 4.45%	7,732 Class A Common Share
Mar 21 2022	SELL Payment of exercise price or tax liability	$13,615 $10.98 p/Share	1,240 Reduced 14.4%	7,372 Class A Common Share
Mar 21 2022	BUY Exercise of conversion of derivative security	-	2,270 Added 20.86%	8,612 Class A Common Share
Mar 16 2022	SELL Payment of exercise price or tax liability	$5,511 $10.13 p/Share	544 Reduced 7.9%	6,342 Class A Common Share
Mar 16 2022	BUY Exercise of conversion of derivative security	-	995 Added 12.63%	6,886 Class A Common Share
Jan 15 2022	BUY Grant, award, or other acquisition	$14,888 $9.63 p/Share	1,546 Added 20.79%	5,891 Class A Common Share
Jul 15 2021	BUY Grant, award, or other acquisition	$11,065 $11.49 p/Share	963 Added 18.14%	4,345 Class A Common Share

Ross Moat

CHIEF COMMERCIAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account